Plasma carboxy-terminal provasopressin (copeptin): A novel marker of insulin resistance and metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2558-2564

  Saleem, Umer ^a   Khaleghi, Mahyar ^a   Morgenthaler, Nils G ^b   Bergmann, Andreas ^b   Struck, Joachim ^b   Mosley Jr , Thomas H ^c   Kullo, Iftikhar J ^a  

^a MAYO CLINIC   (United States)

^b Research Department Brahms AG   (Germany)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; PROVASOPRESSIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE MARKER; EDUCATION; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HISPANIC; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 67650257679     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2278     Document Type: Article

References (40)

1. Grundy SM 2008 Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28:629-636
2. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH 2008 The metabolic syndrome. Endocr Rev 29:777-822
3. Reaven GM, Lithell H, Landsberg L 1996 Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374-381
4. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS 2007 Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115:1345-1353
5. Austin MA, Edwards KL 1996 Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr Opin Lipidol 7:167-171
6. Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy 2nd PF, Kullo IJ 2007 Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 20:83-89
7. Raikkonen K, Keltikangas-Jarvinen L, Adlercreutz H, Hautanen A 1996 Psychosocial stress and the insulin resistance syndrome. Metabolism 45:1533-1538
8. Bjorntorp P, Rosmond R 1999 Hypothalamic origin of the metabolic syndrome X. Ann NY Acad Sci 892:297-307
9. Antoni FA 1993 Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14:76-122
10. Scott LV, Dinan TG 1998 Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci 62:1985-1998
11. Volpi S, Rabadan-Diehl C, Aguilera G 2004 Regulation of vasopressin V1b receptors and stress adaptation. Ann NY Acad Sci 1018:293-301
12. Morgenthaler NG, Struck J, Alonso C, Bergmann A 2006 Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112-119
13. Khaleghi M, Saleem U, Morgenthaler NG, Turner ST, Bergmann A, Struck J, Mosley TH, Kullo IJ 2009 Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension. Am J Hypertens 22:425-431
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
15. 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
16. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C 2004 Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438
17. Morgenthaler NG, Struck J, Jochberger S, Dunser MW 2008 Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 19:43-49
18. Zeger SL, Liang KY 1986 Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130
19. Penit J, Faure M, Jard S 1983 Vasopressin and angiotensin II receptors in rat aortic smooth muscle cells in culture. Am J Physiol 244:E72-E82
20. Volpi S, Rabadan-Diehl C, Aguilera G 2004 Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation. Stress 7:75-83
21. Rosmond R, Dallman MF, Bjorntorp P 1998 Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853-1859
22. Gallo-Payet N, Guillon G 1998 Regulation of adrenocortical function by vasopressin. Horm Metab Res 30:360-367
23. Yibchok-anun S, Abu-Basha EA, Yao CY, Panichkriangkrai W, Hsu WH 2004 The role of arginine vasopressin in diabetes-associated increase in glucagon secretion. Regul Pept 122:157-162
24. Cavagnini F, Croci M, Putignano P, Petroni ML, Invitti C 2000 Glucocorticoids and neuroendocrine function. Int J Obes Relat Metab Disord 24(Suppl 2):S77-S79
25. Papanek PE, Raff H 1994 Physiological increases in cortisol inhibit basal vasopressin release in conscious dogs. Am J Physiol 266:R1744-R1751
26. Montero S, Mendoza H, Valles V, Lemus M, Alvarez-Buylla R, de Alvarez-Buylla ER 2006 Arginine-vasopressin mediates central and peripheral glucose regulation in response to carotid body receptor stimulation with Na-cyanide. J Appl Physiol 100:1902-1909
27. Grazzini E, Breton C, Derick S, Andres M, Raufaste D, Rickwaert F, Boccara G, Colson P, Guerineau NC, Serradeil-le Gal C, Guillon G 1999 Vasopressin receptors in human adrenal medulla and pheochromocytoma. J Clin Endocrinol Metab 84:2195-2203
28. Hems DA, Whitton PD 1973 Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver. Biochem J 136:705-709
29. Dunning BE, Moltz JH, Fawcett CP 1984 Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP). Peptides 5:871-875
30. Lu M, Soltoff SP, Yaney GC, Boyd 3rd AE 1993 The mechanisms underlying the glucose dependence of arginine vasopressin-induced insulin secretion in β-cells. Endocrinology 132:2141-2148
31. Spruce BA, McCulloch AJ, Burd J, Orskov H, Heaton A, Baylis PH, Alberti KG 1985 The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf) 22:463-468
32. Zerbe RL, Vinicor F, Robertson GL 1979 Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 28:503-508
33. Daousi C, Dunn AJ, Foy PM, MacFarlane IA, Pinkney JH 2005 Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. Am J Med 118:45-50
34. Rossi R, Scharrer E 1993 Mechanisms of the effects of vasopressin on plasma levels of free fatty acids and triglycerides in pygmy goats. Comp Biochem Physiol Comp Physiol 104:287-290
35. Traustadottir T, Bosch PR, Matt KS 2005 The HPA axis response to stress in women: effects of aging and fitness. Psychoneuroendocrinology 30:392-402
36. Szinnai G, Morgenthaler NG, Berneis K, Struck J, Muller B, Keller U, Christ-Crain M 2007 Changes in plasma copeptin, the C-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab 92:3973-3978
37. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL 2007 C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide(LAMP)study. Circulation 115:2103-2110
38. Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA, Williams JK 1996 Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models. Psychosom Med 58:598-611
39. Henry JP, Liu YY, Nadra WE, Qian CG, Mormede P, Lemaire V, Ely D, Hendley ED 1993 Psychosocial stress can induce chronic hypertension in normotensive strains of rats. Hypertension 21:714-723
40. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Koyama H, Shoji T, Inaba M, Nishizawa Y 2004 Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab 89:1481-1484